Peptide-Functionalized Biomaterial Platforms for Enhanced Capture of Immature Endothelial Cells
This technology uses specially selected peptides grafted onto biomaterials to efficiently capture and support immature endothelial cells, enabling rapid endothelialization of medical devices, engineered tissues, and in vitro platforms for improved vascular integration and physiological relevance.
Background
The field of vascular tissue engineering and regenerative medicine seeks to address the critical need for functional blood vessel replacements and vascularized engineered tissues. Cardiovascular diseases, trauma, and congenital defects often necessitate the use of vascular grafts, stents, and other implantable devices. However, the long-term success of these interventions is heavily dependent on the rapid and stable formation of an endothelial lining, which mimics the natural blood vessel lining and prevents complications such as thrombosis, inflammation, and restenosis. Immature endothelial cells, including endothelial progenitor cells (EPCs) and endothelial colony forming cells (ECFCs), have emerged as promising candidates for autologous endothelialization due to their proliferative capacity and ability to form mature endothelium. Achieving efficient capture and retention of these cells under physiological blood flow conditions is a major goal in the field, as it is essential for the effective integration and function of vascular implants and engineered tissues.
Despite advances in biomaterial design, current approaches to endothelial cell capture and endothelialization face significant limitations. Many existing strategies rely on the use of extracellular matrix-derived peptides, such as REDV, RGDS, or YIGSRG, grafted onto biomaterial surfaces to promote cell adhesion. While these peptides can facilitate initial cell rolling or weak adhesion, they often fail to support firm capture and stable retention of immature endothelial cells under the dynamic shear forces present in the bloodstream. This results in suboptimal endothelial coverage, delayed healing, and increased risk of device failure or adverse events. Furthermore, the integrin-mediated mechanisms underlying cell adhesion under flow are not fully understood, and the peptides used to date have not been optimized for the specific integrins expressed by target cell populations. As a result, there is a pressing need for more effective biomaterial functionalization strategies that can reliably capture and support immature endothelial cells under physiological conditions, thereby improving the performance and safety of vascular devices and engineered tissues.
Technology
This technology centers on the functionalization of biomaterial substrates with specific integrin-binding peptides to enhance the capture and support of immature endothelial cells, such as endothelial colony forming cells (ECFCs), under physiological shear conditions. By chemically grafting peptides like CRRETAWAC (which targets α5β1 integrin for firm cell capture) and REDV (which targets α4β1 integrin to slow cell rolling) onto a variety of synthetic and natural substrates—including PEG hydrogels, ePTFE, and extracellular matrix proteins—the platform enables integrin-mediated adhesion and subsequent endothelialization. The synergistic combination of these peptides, particularly CRRETAWAC and REDV, significantly increases the efficiency of ECFC capture under flow, supporting the rapid formation of an endothelial layer. This approach is applied to create endothelialized medical devices such as vascular grafts and stents, vascularized engineered tissues, and physiologically relevant in vitro testing platforms.
What differentiates this technology is its precise targeting of integrin-mediated cell adhesion mechanisms under dynamic, physiologically relevant flow conditions, which are critical for successful endothelialization in vivo. Unlike previous solutions that primarily supported cell rolling or static adhesion, this platform enables both the slowing and firm capture of ECFCs, leading to robust endothelial layer formation even under shear stress. The modularity of the peptide-functionalization process allows for broad compatibility with diverse biomaterials and device architectures, while the detailed characterization of peptide combinations and their effects on cell behavior ensures optimized performance. This results in improved integration, reduced thrombogenicity, and enhanced vascularization for implanted devices and engineered tissues, as well as more accurate in vitro models for research and diagnostics.
Benefits
- Enhanced capture and firm adhesion of immature endothelial cells (ECFCs) under physiological shear conditions, improving endothelialization efficiency.
- Synergistic peptide combinations (notably CRRETAWAC and REDV) increase cell capture rates compared to single peptides.
- Versatile peptide grafting onto diverse biomaterial substrates including synthetic polymers, natural matrices, and hydrogels for broad application.
- Supports rapid endothelialization of vascular medical devices (grafts, stents, shunts, valves), reducing risks of thrombosis and restenosis.
- Enables creation of physiologically relevant in vitro platforms (e.g., microfluidic chips) for drug testing and disease modeling.
- Facilitates vascularization in engineered tissues by promoting endothelial cell recruitment and monolayer formation.
- Provides detailed chemical conjugation methods and peptide sequences for reproducible fabrication and customization.
Applications
- Endothelialized vascular grafts
- Endothelialized stents and shunts
- Vascularized engineered tissues
- Organ-on-chip endothelialization
- Endothelial cell capture diagnostics
Additional info
Biomaterial substrates are functionalized with specific peptides, including CRRETAWAC and REDV, to enhance the capture and support of immature endothelial cells (ECFCs) under physiological shear. This surface modification enables integrin-mediated adhesion, promoting endothelialization for medical devices, engineered tissues, and physiologically relevant in vitro testing platforms.